Article

Not All Vaccines Provide Fast and Efficient Protection

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Cirrhosis illustration | Image credit: Rasi - stock.adobe.com
Related Content
Woman Gives Wegovy Shot to Herself at Home - GLP-1 Weight Loss Prescription Medication Has Become Super Popular, Expensive, and Difficult to Obtain - Woman Giving Herself a Shot at Home - Image credit: Matt Fowler KC | stock.adobe.com
September 5th 2025

Semaglutide Receives FDA Approval for Treatment of MASH

Kennedy Ferruggia, Assistant Editor
Hepatitis D blood sample | Image Credit: © Innovative Creation - stock.adobe.com
September 5th 2025

Hepatitis D Reclassified as Carcinogenic, According to WHO

Alexandra Gerlach, Associate Editor
Updated European MASLD Guidelines Review Prevention, Screening, and Treatments
September 5th 2025

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

Huiqiao (Melinda) Fan, BSc
Liver pain: abdominal discomfort, hepatic strain, organ distress, bile issue, jaundice symptom, inflammation, detox failure, cirrhosis sign, liver infection, digestive disturbance.
September 5th 2025

Remnant Cholesterol, Independent of LDL-C, Serves as Predictor of MASLD

Luke Halpern, Assistant Editor
DNA structure and HIV-infected
September 5th 2025

IAS 2025: Patients With HIV Grapple With Healthy Aging, Reducing CVD Risk

Luke Halpern, Assistant Editor
A Novel Agent, Incretin Mimetics, and Potential Pharmacologicals for the Management of MASH
September 5th 2025

A Novel Agent, Incretin Mimetics, and Potential Pharmacologicals for the Management of MASH

Hongxiang Zhao Maria A. Pino, PhD, MS, RPh
© 2025 MJH Life Sciences

All rights reserved.